{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:51:18Z","timestamp":1794009078900,"version":"4.8.0"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Since the World Health Assembly (WHA) in 2012 endorsed the Global Vaccine Action Plan (GVAP), which included regional measles and rubella elimination goals by 2020, global progress towards verification of measles and rubella elimination has been incremental. Even though the 2020 elimination goals were not achieved, commitment towards achieving measles and rubella elimination has been firmly established in the Immunization Agenda 2030 (IA2030) and the Measles and Rubella Strategic Framework (MRSF) 2021\u20132030. In 2023, the six Regional Verification Commissions for measles and rubella elimination (RVCs) reviewed data as of 31 December 2022 and confirmed that 82 (42%) Member States have been verified for measles elimination, and 98 (51%) Member States have been verified for rubella elimination. The six RVCs are composed of independent public health and immunization experts who are well-placed to support accelerating measles and rubella elimination. RVCs should be leveraged not only to review elimination documents but also to advocate for and champion public health programming that supports measles and rubella activities. The verification of elimination process is one of many tools that should be deployed to reinforce and accelerate efforts towards achieving a world free of measles and rubella.<\/jats:p>","DOI":"10.3390\/vaccines12080947","type":"journal-article","created":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:53:37Z","timestamp":1724658817000},"page":"947","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Global Status Report for the Verification of Measles and Rubella Elimination, 2022"],"prefix":"10.3390","volume":"12","author":[{"given":"Patrick","family":"O\u2019Connor","sequence":"first","affiliation":[{"name":"World Health Organization, Headquarters, 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3028-887X","authenticated-orcid":false,"given":"Balcha","family":"Masresha","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for Africa, Brazzaville P.O. Box 06, Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Pastor","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for Americas, Washington, DC 20037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2909-6763","authenticated-orcid":false,"given":"Nasrin","family":"Musa","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for the Eastern Mediterranean, Cairo 11371, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1837-6319","authenticated-orcid":false,"given":"Jos\u00e9","family":"Hagan","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for Europe, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-5375","authenticated-orcid":false,"given":"Sudhir","family":"Khanal","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for South-East Asia, New Delhi 110002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Won","family":"Lee","sequence":"additional","affiliation":[{"name":"World Health Organization, Regional Office for Western Pacific, Manila 1000, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6761-8783","authenticated-orcid":false,"given":"Natasha","family":"Crowcroft","sequence":"additional","affiliation":[{"name":"World Health Organization, Headquarters, 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"World Health Organization (2011). Proceedings of the global technical consultation to assess the feasibility of measles eradication, 28\u201330 July 2010. J. Infect. Dis., 204, S4\u2013S13.","DOI":"10.1093\/infdis\/jir100"},{"key":"ref_2","unstructured":"World Health Organization (2011). Meeting of the Strategic Advisory Group of Experts on Immunization, November 2010 Summary, Conclusions, and Recommendations. Wkly. Epidemiol. Rec. (WER), 86, 1\u201316. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/241695\/WER8601_02_1-16.pdf?sequence=1."},{"key":"ref_3","unstructured":"World Health Organization (2012). Sixty-Fifth World Health Assembly, World Health Organization. Available online: http:\/\/apps.who.int\/gb\/DGNP\/pdf_files\/A65_REC1-en.pdf."},{"key":"ref_4","unstructured":"World Health Organization (2013). Global Vaccine Action Plan 2011\u20132020, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/global-vaccine-action-plan-2011-2020."},{"key":"ref_5","unstructured":"World Health Organization (2020). Global Vaccine Action Plan Monitoring, Evaluation & Accountability: Secretariat Annual Report 2020, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/global-vaccine-action-plan-monitoring-evaluation-accountability-secretariat-annual-report-2020."},{"key":"ref_6","unstructured":"World Health Organization (2020). Immunization Agenda 2030: A Global Strategy to Leave No One Behind, World Health Organization. Available online: https:\/\/www.who.int\/publications\/m\/item\/immunization-agenda-2030-a-global-strategy-to-leave-no-one-behind."},{"key":"ref_7","unstructured":"World Health Organization (2020). Measles and Rubella Strategic Framework: 2021\u20132030, World Health Organization. Available online: https:\/\/www.who.int\/publications\/i\/item\/measles-and-rubella-strategic-framework-2021-2030."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.vaccine.2023.07.033","article-title":"Modeling the impact of vaccination for the Immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030","volume":"42","author":"Carter","year":"2023","journal-title":"Vaccine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijid.2023.09.003","article-title":"Estimates of the global burden of Congenital Rubella Syndrome, 1996\u20132019","volume":"137","author":"Vynnycky","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"ref_10","unstructured":"Pan American Health Organization (1994). 24th Pan American Sanitary Conference, Pan American Health Organization. Available online: http:\/\/iris.paho.org\/bitstream\/handle\/10665.2\/57514\/CSP24-res_eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_11","unstructured":"World Health Organization (2011). Sixty-First Session of the WHO Regional Committee for Africa, World Health Organization, Regional Office for Africa. Available online: http:\/\/iris.who.int\/bitstream\/handle\/10665\/259610\/AFR-RC61-R1-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_12","unstructured":"World Health Organization (2015). Sixty-Second Session of the Regional Committee for the Eastern Mediterranean, World Health Organization, Regional Office for Eastern Mediterranean. Available online: https:\/\/applications.emro.who.int\/docs\/RC_final_Rep_2015_16735_EN.pdf?ua=1."},{"key":"ref_13","unstructured":"World Health Organization (2014). Sixty-Fourth Session of the WHO Regional Committee for Europe, World Health Organization, Regional Office for Europe. Available online: http:\/\/iris.who.int\/bitstream\/handle\/10665\/337451\/64rp00e-Rep-140754.pdf?sequence=1&isAllowed=y."},{"key":"ref_14","unstructured":"World Health Organization (2019). Seventy-Second Session of the Regional Committee, World Health Organization, Regional Office for South-East Asia. Available online: http:\/\/iris.who.int\/bitstream\/handle\/10665\/327923\/sea-rc72-r3-eng.pdf?sequence=1."},{"key":"ref_15","unstructured":"World Health Organization (2017). Sixty-Eighth Session of the Regional Committee, World Health Organization, Regional Office for the Western Pacific. Available online: http:\/\/iris.who.int\/bitstream\/handle\/10665\/361628\/WPR-RC068-Res01-2017-en.pdf."},{"key":"ref_16","unstructured":"World Health Organization (2018). Guidance for evaluating progress towards elimination of measles and rubella. Wkly. Epidemiol. Rec. (WER), 93, 541\u2013552. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/275394\/WER9341-544-552.pdf?sequence=1&isAllowed=y."},{"key":"ref_17","unstructured":"World Health Organization, Regional Office for Africa (2023). Proceedings of the 3rd Meeting of the African Regional Commission for the Verification of Measles Elimination (RVC), World Health Organization."},{"key":"ref_18","unstructured":"World Health Organization, Regional Office for South-East Asia (2023). Eighth Meeting of the WHO South-East Asia Regional Verification Commission for Measles and Rubella, World Health Organization. Available online: http:\/\/iris.who.int\/handle\/10665\/370787."},{"key":"ref_19","unstructured":"World Health Organization, Regional Office for the Western Pacific (2023). Eleventh Annual Meeting of the Regional Verification Commission for Measles and Rubella Elimination in the Western Pacific, World Health Organization."},{"key":"ref_20","unstructured":"World Health Organization, Regional Office for Europe (2023). Twelfth Meeting of the European Regional Verification Commission for Measles and Rubella, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/376606\/WHO-EURO-2024-9722-49494-74055-eng.pdf?sequence=1."},{"key":"ref_21","unstructured":"Pan American Health Organization, and World Health Organization, Regional Office of the Americas (2023). Third Annual Meeting of the Measles and Rubella and Congenital Rubella Syndrome Post Elimination Regional Monitoring and Re-verification Commission (Virtual), World Health Organization, Regional Office of the Americas. Pan American Health Organization."},{"key":"ref_22","unstructured":"World Health Organization, Regional Office for the Eastern Mediterranean (2024). Sixth Meeting of the Regional Verification Commission of Measles and Rubella Elimination in the Eastern Mediterranean Region, World Health Organization. Available online: https:\/\/iris.who.int\/bitstream\/handle\/10665\/376390\/WHOEMEPI363E-eng.pdf?sequence=1&isAllowed=y."},{"key":"ref_23","unstructured":"World Health Organization (2024). Vaccination Schedule for Measles, Vaccination Schedule for Rubella, World Health Organization. Available online: https:\/\/immunizationdata.who.int\/global?topic=Vaccination-schedule&location=."},{"key":"ref_24","unstructured":"World Health Organization (2023). The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond, The United Nations Children\u2019s Fund (UNICEF). Available online: https:\/\/www.who.int\/publications\/i\/item\/9789240075511."},{"key":"ref_25","unstructured":"World Health Organization (2020). Leave No One Behind: Guidance for Planning and Implementing Catch-Up Vaccination\u2013Working Draft, World Health Organization. Available online: https:\/\/www.who.int\/docs\/default-source\/immunization\/catch-up\/who-catch-up-guidance-working-draft-11-08-20.pdf?sfvrsn=6d65982a_4."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e1412","DOI":"10.1016\/S2214-109X(22)00335-7","article-title":"Feasibility of measles and rubella vaccination programmes for disease elimination: A modelling study","volume":"10","author":"Winter","year":"2022","journal-title":"Lancet Glob. Health"}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/8\/947\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:41:06Z","timestamp":1760110866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/12\/8\/947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,22]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["vaccines12080947"],"URL":"https:\/\/doi.org\/10.3390\/vaccines12080947","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,22]]}}}